Skip to main navigation
Skip to search
Skip to main content
Korea University Pure Home
Search content at Korea University Pure
Home
Profiles
Research units
Equipment
Research output
Press/Media
Pharmacotherapy for late-life depression
Kyu Man Han
*
*
Corresponding author for this work
Department of Biomedical Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacotherapy for late-life depression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacotherapy
100%
Late-life Depression
100%
Antidepressants
62%
Older Adults
37%
Diagnostic Criteria
25%
Clinical Features
25%
Adverse Effects
25%
Comorbid Conditions
25%
Elderly Patients
25%
Elderly Adults
12%
Cognitive Impairment
12%
Clinical Practice Guidelines
12%
Young Patients
12%
Mirtazapine
12%
Monotherapy
12%
Antidepressant Treatment
12%
Remission
12%
Serotonin-norepinephrine Reuptake Inhibitors
12%
Selective Serotonin Reuptake Inhibitors
12%
Bupropion
12%
Serious Adverse Effects
12%
Drug Interactions
12%
Clinical Evidence
12%
Starting Dose
12%
Clinical Diagnostics
12%
Pharmacological Treatment
12%
Patient Needs
12%
Maintenance Treatment
12%
Vortioxetine
12%
Prevent Recurrence
12%
Polypharmacy
12%
Depression in Elderly
12%
Chronic Course
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Late Life Depression
100%
Antidepressant
75%
Recurrent Disease
25%
Clinical Feature
25%
Selective Serotonin Reuptake Inhibitor
25%
Monotherapy
12%
Remission
12%
Drug Interaction
12%
Cognitive Defect
12%
Serotonin-Norepinephrine Reuptake Inhibitor
12%
Mirtazapine
12%
Vortioxetine
12%
Polypharmacy
12%
Bupropion
12%